Page last updated: 2024-08-18

pyrroles and rifampin

pyrroles has been researched along with rifampin in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-199010 (28.57)18.7374
1990's1 (2.86)18.2507
2000's11 (31.43)29.6817
2010's7 (20.00)24.3611
2020's6 (17.14)2.80

Authors

AuthorsStudies
Friedman, PA; Goldberg, IH1
Arcamone, F; Casazza, AM; Chandra, P; Di Marco, A; Gericke, D; Ghione, M; Giuliani, F; Götz, A; Soranzo, C; Thorbeck, R; Zunino, F1
Brown, LR; Haworth, SR1
Becker, Y; Kotler, M2
Arioli, V; Maggi, N; Tamborini, G1
Ishihama, A; Iwakura, Y; Yura, T1
Khachatourians, GG; Tipper, DJ1
Becher, H; Böhlandt, D; Grunicke, H; Puschendorf, B1
Devine, LF; Hagerman, CR1
Beale, SI; Rhie, G1
Biava, M; Cesare Porretta, G; Deidda, D; Manetti, F; Pompei, R; Tafi, A1
Alonso Lomillo, MA; Arcos Martinez, MJ; Kauffmann, JM1
Backman, JT; Luurila, H; Neuvonen, M; Neuvonen, PJ1
Benet, LZ; Huang, Y; Lau, YY; Okochi, H2
Kivistö, KT1
Benet, LZ; Frassetto, L; Huang, Y; Lau, YY1
Cía, M; Martínez, M; Otermin, I; Pereda, A; Rivero, M1
de Barros e Silva, MJ; de Paiva, TF; Fanelli, MF; Gimenes, DL; Rinck, JA1
Chen, BL; Chen, Y; Guo, D; He, YJ; Kirchheiner, J; Li, Z; Tan, ZR; Tu, JH; Xu, LY; Yu, BN; Zhang, W; Zhou, G; Zhou, HH1
Srinivas, NR1
Rao, N1
Alfonso, S; Battilocchio, C; Biava, M; Botta, M; De Logu, A; Manetti, F; Poce, G; Porretta, GC; Serra, N1
Chang, JH; Cheong, J; Ly, J; Messick, K; Plise, E; Wright, M; Zhang, X1
da Silva, MG; do Nascimento, DC; Duarte, RS; Ferreira, Jda S; Hacker, MA; Lara, FA; Lobato, LS; Monteiro, CP; Moraes, MO; Neumann, Ada S; Oliveira, DS; Pedrini, SC; Pereira, GM; Pessolani, MC; Ribeiro-Alves, M; Rosa, PS; Soares, CT1
Bharate, JB; Bharate, SB; Joshi, P; Khan, IA; Kumar, A; Sharma, S; Singh, S; Vishwakarma, RA; Wani, A1
Basher, MA; Bhakta, S; Brucoli, F; Evangelopoulos, D; Fox, KR; Guzman, JD; McHugh, TD; McMahon, E; Munshi, T1
Brucoli, F; Fattorini, L; Giannoni, F; Iacobino, A1
Irie, S; Ishizuka, H; Ishizuka, T; Kato, M; Kirigaya, Y; Nakatsu, T; Nishikawa, Y; Shimizu, T; Shiramoto, M; Uchimaru, H1
Bruce, KD; Clifton, LA; Dreiss, CA; González-Gaitano, G; Harvey, RD; Picconi, P; Rahman, KM; Skoda, MWA; Valero, M; Vandera, KA; Woods, A; Zain, NMM1
Igawa, Y; Ishizuka, H; Ishizuka, T; Shimizu, T; Watanabe, A; Yamada, M1
Chen, X; Ji, T; Yeleswaram, S1
Beelen, A; Curd, L; Goti, V; Horton, JK; Li, C; Sale, M; Tao, W1
Cao, Y; Fu, Y; Gao, X; Jiang, X; Li, T; Li, X; Lin, P; Liu, Y; Shi, P; Sun, F; Wang, C; Zhang, Y1

Reviews

1 review(s) available for pyrroles and rifampin

ArticleYear
Antibiotics and nucleic acids.
    Annual review of biochemistry, 1971, Volume: 40

    Topics: Anthracenes; Anthraquinones; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Benzazepines; Bleomycin; Chemical Phenomena; Chemistry; Dactinomycin; Daunorubicin; DNA; DNA Nucleotidyltransferases; Escherichia coli; Glycosides; Metabolism; Mitomycins; Models, Structural; Mycotoxins; Naphthacenes; Nucleic Acids; Olivomycins; Peptides; Plicamycin; Pyrroles; Rifampin; RNA; RNA Nucleotidyltransferases; Streptonigrin; Streptovaricin; Templates, Genetic

1971

Trials

4 trial(s) available for pyrroles and rifampin

ArticleYear
Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
    Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:2

    Topics: Adult; Area Under Curve; Atorvastatin; Cross-Over Studies; Drug Interactions; Female; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Pyrroles; Rifampin

2005
effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.
    Clinical pharmacology and therapeutics, 2007, Volume: 81, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Atorvastatin; Bile; Binding, Competitive; Biological Transport; Cell Line; Cross-Over Studies; Enzyme Inhibitors; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intravenous; Liver; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Organic Anion Transporters; Pyrroles; Rifampin; Substrate Specificity; Tablets; Transfection

2007
Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:1

    Topics: Antihypertensive Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Japan; Liver Failure; Metabolic Clearance Rate; Models, Biological; Pyrroles; Rifampin; Sulfones

2022
Pharmacokinetic Drug-Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer.
    Clinical drug investigation, 2022, Volume: 42, Issue:8

    Topics: Area Under Curve; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Lung Neoplasms; Metformin; Midazolam; Prospective Studies; Pyrimidines; Pyrroles; Rifampin; Topotecan

2022

Other Studies

30 other study(ies) available for pyrroles and rifampin

ArticleYear
Influence of some antitumor antibiotics on viral neoplasia. The role of molecular structure in the inhibition of DNA polymerases from RNA tumor viruses, viral multiplication and tumor growth by some antitumor antibiotics.
    Die Naturwissenschaften, 1972, Volume: 59, Issue:10

    Topics: Amidines; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Daunorubicin; DNA Nucleotidyltransferases; Female; Male; Mice; Oncogenic Viruses; Peptides; Piperazines; Pyrroles; Reverse Transcriptase Inhibitors; Rifampin; RNA Viruses; Structure-Activity Relationship; Virus Replication

1972
Genetic analysis of ribonucleic acid polymerase mutants of Bacillus subtilis.
    Journal of bacteriology, 1973, Volume: 114, Issue:1

    Topics: Alkanesulfonates; Anti-Bacterial Agents; Bacillus subtilis; Bacteriophage Typing; Chromosome Mapping; Crosses, Genetic; Culture Media; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Microbial; Genetic Code; Mutation; Pyrans; Pyrroles; Rifampin; Spores, Bacterial; Streptovaricin; Temperature; Transduction, Genetic; Transformation, Genetic

1973
Rifampicin and distamycin A as inhibitors of Rous sarcoma virus reverse transcriptase.
    Nature: New biology, 1971, Sep-15, Volume: 234, Issue:50

    Topics: Anti-Bacterial Agents; Avian Sarcoma Viruses; Dactinomycin; DNA Nucleotidyltransferases; DNA, Viral; Hydrazones; Kinetics; Osmolar Concentration; Peptides; Pyrroles; Rifampin; Structure-Activity Relationship; Thymine Nucleotides; Tritium

1971
[The effect of rifampicin and distamycin A on DNA synthesis by RNA-dependent DNA polymerases of Rous sarcoma virus].
    Harefuah, 1971, Nov-01, Volume: 81, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Avian Sarcoma Viruses; Chick Embryo; Dactinomycin; DNA Nucleotidyltransferases; DNA, Viral; Peptides; Pyrroles; Rifampin; RNA, Viral; Templates, Genetic

1971
[Pyrrolo-rifamycin: synthesis and antibacterial properties].
    Il Farmaco; edizione scientifica, 1969, Volume: 24, Issue:3

    Topics: Animals; Chromatography, Thin Layer; Enterococcus faecalis; Escherichia coli; Injections, Intradermal; Intestinal Absorption; Mice; Mycobacterium tuberculosis; Pseudomonas aeruginosa; Pyrroles; Rifampin; Staphylococcus; Streptococcus pneumoniae

1969
RNA polymerase mutants of Escherichia coli. Streptolydigin resistance and its relation to rifampicin resistance.
    Molecular & general genetics : MGG, 1973, Mar-01, Volume: 121, Issue:2

    Topics: Anti-Bacterial Agents; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Escherichia coli; Genetics, Microbial; Mutation; Peptide Chain Elongation, Translational; Peptide Chain Initiation, Translational; Pyrans; Pyrroles; Rifampin; RNA

1973
Inhibition of messenger ribonucleic acid synthesis in Escherichia coli by thiolutin.
    Journal of bacteriology, 1974, Volume: 119, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Carbon Radioisotopes; Cell-Free System; Escherichia coli; Galactose; Galactosidases; Glycosides; Nitrobenzenes; Protein Biosynthesis; Pyrroles; Rifampin; RNA, Bacterial; RNA, Messenger; Transcription, Genetic; Tritium; Uridine

1974
Effect of distamycin A on T4-DNA-directed RNA synthesis.
    European journal of biochemistry, 1974, Dec-02, Volume: 49, Issue:3

    Topics: Amidines; Anti-Bacterial Agents; Coliphages; DNA Viruses; DNA-Directed RNA Polymerases; DNA, Viral; Escherichia coli; Kinetics; Oligopeptides; Protein Binding; Pyrroles; Ribonucleotides; Rifampin; Time Factors; Transcription, Genetic

1974
Spectra of susceptibility of Neisseria meningitidis to antimicrobial agents in vitro.
    Applied microbiology, 1970, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Carrier State; Disinfectants; Humans; Microbial Sensitivity Tests; Nasopharynx; Neisseria meningitidis; Pyrroles; Rifampin; Sulfonamides

1970
Regulation of heme oxygenase activity in Cyanidium caldarium by light, glucose, and phycobilin precursors.
    The Journal of biological chemistry, 1994, Apr-01, Volume: 269, Issue:13

    Topics: Aminolevulinic Acid; Bacterial Proteins; Chloramphenicol; Cyclohexanecarboxylic Acids; Cycloheximide; Darkness; Enzyme Induction; Gene Expression; Glucose; Heme Oxygenase (Decyclizing); Light; Light-Harvesting Protein Complexes; Phycobilins; Phycocyanin; Plant Proteins; Pyrroles; Rhodophyta; Rifampin; Tetrapyrroles

1994
Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.
    Bioorganic & medicinal chemistry, 2003, Feb-20, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Agents; Antiviral Agents; Binding Sites; Chemical Phenomena; Chemistry, Physical; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Morpholines; Mycobacterium; Piperazines; Pyrroles; Rifampin; Streptomycin; Structure-Activity Relationship

2003
HRP-based biosensor for monitoring rifampicin.
    Biosensors & bioelectronics, 2003, Aug-15, Volume: 18, Issue:9

    Topics: Biosensing Techniques; Coated Materials, Biocompatible; Drug Contamination; Electrochemistry; Enzymes, Immobilized; Horseradish Peroxidase; Polymers; Pyrroles; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Urinalysis

2003
Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:2

    Topics: Animals; Area Under Curve; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cell Line; Dose-Response Relationship, Drug; Heptanoic Acids; Liver; Male; Microsomes, Liver; Organic Anion Transporters; Pyrroles; Rats; Rats, Sprague-Dawley; Rifampin; Tissue Distribution

2006
Comments on "Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: Application of in vitro and ex situ systems".
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:3

    Topics: Animals; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cytochrome P-450 CYP3A; Drug Interactions; Heptanoic Acids; Liver; Organic Anion Transporters; Pyrroles; Rats; Rifampin

2006
Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:7

    Topics: Administration, Oral; Animals; Antibiotics, Antitubercular; Atorvastatin; Biological Availability; Drug Interactions; Heptanoic Acids; Hydroxylation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections, Intravenous; Intestinal Mucosa; Intestines; Liver; Male; Microsomes; Organic Anion Transporters; Pyrroles; Rats; Rats, Sprague-Dawley; Rifampin

2006
[Musculoskeletal adverse effects of levofloxacin].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:4

    Topics: Anti-Bacterial Agents; Arthralgia; Arthritis; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Atorvastatin; Combined Modality Therapy; Debridement; Diagnosis, Differential; Doxycycline; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Levofloxacin; Middle Aged; Ofloxacin; Postoperative Complications; Prosthesis-Related Infections; Pyrroles; Recurrence; Reoperation; Rifampin; Thyroiditis, Autoimmune; Thyroxine; Trimethoprim, Sulfamethoxazole Drug Combination

2006
Tuberculosis in a patient on temozolomide: a case report.
    Journal of neuro-oncology, 2009, Volume: 92, Issue:1

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antibiotics, Antitubercular; Anticholesteremic Agents; Anticonvulsants; Antineoplastic Agents, Alkylating; Atorvastatin; Brain Neoplasms; Combined Modality Therapy; Cyclosporine; Dacarbazine; Dexamethasone; Female; Fluoxetine; Glioblastoma; Heptanoic Acids; Humans; Immunosuppressive Agents; Isoniazid; Middle Aged; Omeprazole; Phenobarbital; Prednisone; Pyrazinamide; Pyrroles; Radiotherapy; Red-Cell Aplasia, Pure; Rifampin; Temozolomide; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary

2009
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism.
    Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 405, Issue:1-2

    Topics: Atorvastatin; Genotype; Heptanoic Acids; Humans; Kinetics; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Polymorphism, Genetic; Pyrroles; Rifampin; Thymidine; Young Adult

2009
Efflux transporter-mediated interactions with atorvastatin--interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:12

    Topics: Anticholesteremic Agents; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Heptanoic Acids; Humans; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters; Purines; Pyrroles; Rifampin; Verapamil

2009
Re: Efflux transporter-mediated interactions with atorvastatin--interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin.
    Journal of clinical pharmacology, 2011, Volume: 51, Issue:5

    Topics: Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Anion Transporters; Purines; Pyrroles; Research Design; Rifampin; Verapamil

2011
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin.
    Bioorganic & medicinal chemistry, 2010, Nov-15, Volume: 18, Issue:22

    Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Mycobacterium tuberculosis; Pyrroles; Rifampin; Streptomycin; Structure-Activity Relationship; Vero Cells

2010
Differential effects of Rifampin and Ketoconazole on the blood and liver concentration of atorvastatin in wild-type and Cyp3a and Oatp1a/b knockout mice.
    Drug metabolism and disposition: the biological fate of chemicals, 2014, Volume: 42, Issue:6

    Topics: Animals; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; HEK293 Cells; Heptanoic Acids; Humans; Ketoconazole; Liver; Mice; Mice, Knockout; Organic Anion Transport Protein 1; Pyrroles; Rifampin

2014
Statins increase rifampin mycobactericidal effect.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Animals; Antitubercular Agents; Atorvastatin; Cell Line; Drug Synergism; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leprosy; Macrophages; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Mycobacterium tuberculosis; Pyrroles; Rifampin; Simvastatin

2014
Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
    Organic & biomolecular chemistry, 2015, May-21, Volume: 13, Issue:19

    Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Binding Sites; Biological Transport; Caco-2 Cells; Ciprofloxacin; Coumarins; Dogs; Ethidium; Humans; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Models, Molecular; Multidrug Resistance-Associated Proteins; Pyrroles; Rifampin; Staphylococcus aureus

2015
DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.
    The Journal of antibiotics, 2016, Volume: 69, Issue:12

    Topics: Animals; Antitubercular Agents; Base Sequence; Benzodiazepines; Deoxyribonuclease I; DNA Footprinting; DNA, Bacterial; Escherichia coli; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Nylons; Pseudomonas putida; Pyrroles; RAW 264.7 Cells; Rhodococcus; Rifampin; Sequence Analysis, DNA

2016
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions.
    The Journal of antibiotics, 2018, Volume: 71, Issue:9

    Topics: Anaerobiosis; Antitubercular Agents; Benzodiazepines; Cell Line; Humans; Isoniazid; Mycobacterium tuberculosis; Nylons; Pyrroles; Rifampin; Tuberculosis, Pulmonary

2018
Effects of itraconazole and rifampicin on the single-dose pharmacokinetics of the nonsteroidal mineralocorticoid receptor blocker esaxerenone in healthy Japanese subjects.
    British journal of clinical pharmacology, 2020, Volume: 86, Issue:10

    Topics: Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Japan; Male; Pyrroles; Receptors, Mineralocorticoid; Rifampin; Sulfones

2020
Antibiotic-in-Cyclodextrin-in-Liposomes: Formulation Development and Interactions with Model Bacterial Membranes.
    Molecular pharmaceutics, 2020, 07-06, Volume: 17, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane; Benzodiazepines; Cell Membrane Permeability; Cyclodextrins; Drug Compounding; Drug Delivery Systems; Drug Resistance, Bacterial; Escherichia coli; Lipid Bilayers; Liposomes; Membrane Fusion; Models, Biological; Pyrroles; Rifampin; Solubility

2020
Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling.
    CPT: pharmacometrics & systems pharmacology, 2022, Volume: 11, Issue:7

    Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Itraconazole; Models, Biological; Morpholines; Pyrimidines; Pyrroles; Rifampin

2022
The effect of rifampin on the pharmacokinetics of famitinib in healthy subjects.
    Cancer chemotherapy and pharmacology, 2022, Volume: 90, Issue:5

    Topics: Chromatography, Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Drug Interactions; Healthy Volunteers; Humans; Indoles; Male; Pyrroles; Rifampin; Tandem Mass Spectrometry

2022